Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Effect of CCX140-B on Albuminuria in Subjects With Type 2 Diabetes Mellitus
Conditions
Interventions
Placebo
CCX140-B
Locations
1
Netherlands
Centre for Human Drug Research
Leiden, Netherlands
Start Date
September 1, 2011
Primary Completion Date
February 1, 2013
Completion Date
September 1, 2013
Last Updated
February 27, 2025
NCT07232537
NCT06278207
NCT07051005
NCT06887049
NCT07433062
NCT04943861
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions